Andarine (S-4) 10 mg – 100 Capsules

Biochem Andarine (S-4) 10 mg – 100 Capsules | Selective Androgen Receptor Modulator (SARM)

Biochem Andarine (S-4) 10 mg – 100 Capsules is an oral capsule product containing the compound andarine, also known as S-4, a nonsteroidal selective androgen receptor modulator (SARM) developed for investigation of androgen receptor activity in muscle and bone tissue.

This product contains 10 mg of andarine per capsule, with 100 capsules per package, representing 1,000 mg (1 gram) of andarine per package based on the stated formulation.

Andarine belongs to a class of experimental compounds designed to interact selectively with androgen receptors. These receptors are involved in the regulation of skeletal muscle, bone metabolism, reproductive physiology, and numerous androgen-dependent biological processes.

Unlike traditional anabolic-androgenic steroids, andarine does not possess the characteristic steroidal chemical structure of testosterone-derived compounds.

Instead, it is a synthetic nonsteroidal molecule that binds to androgen receptors and influences receptor-mediated gene transcription.

Andarine was investigated in preclinical development programs for potential applications involving muscle wasting, bone loss, and other conditions associated with reduced androgen activity.

Its development was based on the possibility of producing tissue-selective androgen receptor effects. However, tissue selectivity does not establish that andarine is free from androgen-related adverse effects.

Andarine is commonly identified by the development code S-4 and is frequently discussed alongside other selective androgen receptor modulators, including ostarine (MK-2866), ligandrol (LGD-4033), and RAD-140.

These compounds differ in their chemical structures, receptor interactions, pharmacokinetics, and available evidence.

Andarine has not been established as a safe or effective treatment for increasing muscle mass, improving athletic performance, treating osteoporosis, or managing hormonal disorders in humans.

Human clinical safety and efficacy data are insufficient to establish a therapeutic dosage, long-term safety profile, or approved medical indication.

Reports of visual disturbances, including changes in color perception and adaptation between light and darkness, are particularly associated with andarine in informal user accounts. The incidence, mechanism, and reversibility of these effects have not been adequately established in controlled human studies.

Andarine may also affect endogenous reproductive hormone regulation, liver function, lipid metabolism, and other androgen-responsive systems. The extent of these risks remains uncertain.

Andarine is prohibited in sport under the World Anti-Doping Agency's anabolic agents category.

The Biochem brand name does not independently establish pharmaceutical approval, manufacturing quality, analytical purity, or clinical suitability.

1. Interacts With Androgen Receptors

Andarine is a synthetic, nonsteroidal compound developed to bind to androgen receptors.

Androgen receptors are intracellular proteins that regulate the expression of genes involved in muscle, bone, reproductive physiology, and other biological processes.

Binding of an androgen receptor ligand can change receptor conformation and influence interactions with transcriptional regulatory proteins.

The resulting biological effects depend on tissue characteristics, receptor activity, and the compound's intrinsic pharmacological properties.

2. Was Developed for Tissue-Selective Androgen Receptor Activity

The development of SARMs was motivated by the possibility of influencing androgen-responsive tissues without reproducing every effect associated with traditional anabolic-androgenic steroids.

Andarine was studied in this context, particularly in relation to skeletal muscle and bone.

However, preclinical tissue-selective effects cannot be assumed to translate into a favorable human safety profile.

3. Has Been Investigated in Skeletal Muscle Research

Androgen receptor signaling contributes to the regulation of skeletal muscle protein metabolism and tissue maintenance.

Andarine has been examined in preclinical models involving androgen-responsive tissues.

These investigations do not establish that andarine safely increases muscle mass, strength, endurance, or athletic performance in humans.

4. Has Been Investigated in Bone Metabolism Research

Androgen signaling also influences bone remodeling and skeletal physiology.

Preclinical SARM research has examined whether compounds such as andarine can affect bone-related biological pathways.

Andarine has no established clinical indication for osteoporosis or fracture prevention.

5. Differs Chemically From Anabolic-Androgenic Steroids

Andarine is nonsteroidal and does not share the classical steroid nucleus found in testosterone and many anabolic-androgenic steroids.

Nevertheless, its interaction with androgen receptors means that some biological effects and safety concerns may overlap with those of other androgen-active substances.

A nonsteroidal chemical structure should not be interpreted as evidence of safety.

6. Has an Incompletely Characterized Human Pharmacokinetic Profile

Reliable, comprehensive human pharmacokinetic data for andarine are limited.

Its oral bioavailability, metabolic pathways, elimination characteristics, and clinically relevant drug interactions have not been sufficiently characterized to establish standardized human treatment regimens.

Specific numerical half-life claims circulating online should not be treated as established human pharmacokinetic facts without supporting clinical evidence.

7. Has Significant Unresolved Safety Concerns

Visual disturbances are among the most frequently discussed adverse effects associated with andarine.

Informal reports describe altered color perception, yellow-tinted vision, and difficulty adapting between bright and dark environments.

Other potential concerns include suppression of endogenous reproductive hormones, adverse lipid changes, liver injury, and cardiovascular effects.

The frequency, severity, long-term consequences, and reversibility of these effects have not been adequately established.

Andarine is not an approved treatment for muscle wasting, osteoporosis, erectile dysfunction, testosterone deficiency, or athletic performance enhancement. The 10 mg capsule strength describes the product presentation and is not a medically validated human dose.

Step 1 – Oral Capsule Administration

Andarine is presented in oral capsule form.

Following ingestion, the compound would need to dissolve and be absorbed through the gastrointestinal tract before producing systemic effects.

Human absorption characteristics for this formulation have not been independently established.

Step 2 – Distribution to Androgen-Responsive Tissues

Following systemic absorption, an androgen receptor ligand may distribute to tissues containing androgen receptors.

Potential target tissues include skeletal muscle, bone, and other androgen-responsive organs.

The tissue distribution of this specific Biochem formulation has not been established.

Step 3 – Interaction With Androgen Receptors

Andarine interacts with androgen receptors and may influence receptor conformation and transcriptional signaling.

The receptor response depends on the compound's pharmacological activity and the characteristics of the target tissue.

Step 4 – Modulation of Androgen-Responsive Gene Expression

Androgen receptor activation or modulation can influence gene expression associated with tissue metabolism and physiological regulation.

Preclinical observations cannot independently establish clinical benefits in humans.

Step 5 – Metabolism and Elimination

Following systemic exposure, andarine is expected to undergo metabolic processing and elimination.

However, reliable human data describing its metabolic pathways, elimination half-life, and clinically significant interactions remain insufficient.

The Biochem Andarine 10 mg capsule presentation includes the following product characteristics:

• Andarine (S-4) as the active compound.
• 10 mg per capsule.
• 100 capsules per package.
• 1,000 mg total active ingredient content.
• Oral capsule presentation.
• Nonsteroidal chemical classification.
• Selective androgen receptor modulator classification.
• Androgen receptor-binding activity.
• Interaction with nuclear receptor signaling.
• Modulation of androgen-responsive gene transcription.
• Preclinical investigation involving skeletal muscle.
• Preclinical investigation involving bone metabolism.
• No established human therapeutic indication.
• No validated human dosing regimen.
• Limited human clinical safety evidence.
• Incompletely characterized human pharmacokinetics.
• Reported visual disturbances.
• Potential endocrine and reproductive effects.
• Potential liver and lipid-related adverse effects.
• Prohibited status under WADA rules.
• Capsule excipients requiring confirmation.
• Identity, purity, and content uniformity requiring independent analytical verification.

The precise excipient composition, capsule appearance, manufacturing specifications, purity, and analytical content of Biochem Andarine 10 mg have not been independently verified.

The product description identifies the requested composition of 100 capsules containing 10 mg each. It does not establish regulatory authorization, clinical safety, or suitability for human administration.

United States

Biochem Andarine 10mg, Biochem S4 10mg, Andarine 10mg 100 capsules, S4 100 capsules, Andarine United States, Andarine selective androgen receptor modulator, S4 SARM compound, Andarine molecular formula, Andarine chemical structure, S4 androgen receptor activity, Andarine pharmacology, Andarine preclinical studies, S4 muscle tissue research, Andarine bone metabolism, Andarine visual disturbances, S4 safety concerns, Andarine clinical evidence, Andarine capsule specifications.

Canada

English: Biochem Andarine 10mg Canada, S4 10mg Canada, Andarine 100 capsules, Andarine SARM, selective androgen receptor modulator, Andarine properties, S4 pharmacology, Andarine molecular structure, S4 androgen receptor, Andarine preclinical research, Andarine visual effects, S4 safety information, Andarine clinical evidence.

French: Biochem Andarine 10 mg Canada, Andarine S4 10 mg, Andarine 100 capsules, modulateur sélectif des récepteurs aux androgènes, propriétés de l'andarine, pharmacologie du S4, récepteur aux androgènes, structure moléculaire de l'andarine, études précliniques, métabolisme osseux, tissu musculaire, troubles visuels signalés, informations de sécurité, données cliniques limitées.

United Kingdom

Biochem Andarine 10mg UK, Andarine S4 UK, Andarine 100 capsules, selective androgen receptor modulator, S4 SARM, Andarine pharmacology, Andarine chemical structure, S4 androgen receptor binding, Andarine preclinical studies, Andarine muscle biology, S4 bone metabolism, Andarine visual disturbances, S4 safety profile, Andarine clinical evidence.

Germany

Biochem Andarine 10 mg Deutschland, Andarine S4, Andarine 100 Kapseln, selektiver Androgenrezeptormodulator, SARM Andarine, Andarine Eigenschaften, S4 Wirkungsmechanismus, Androgenrezeptor, Andarine Molekülstruktur, präklinische Studien, Muskelgewebe Forschung, Knochenstoffwechsel, Sehstörungen, Sicherheitsinformationen, begrenzte klinische Daten.

France

Biochem Andarine 10 mg France, Andarine S4, Andarine 100 gélules, modulateur sélectif des récepteurs aux androgènes, SARM Andarine, propriétés de l'andarine, mécanisme d'action du S4, récepteur aux androgènes, structure moléculaire, études précliniques, tissu musculaire, métabolisme osseux, troubles visuels, informations de sécurité, données cliniques limitées.

Spain

Biochem Andarine 10 mg España, Andarine S4, Andarine 100 cápsulas, modulador selectivo del receptor de andrógenos, SARM Andarine, propiedades de la andarina, mecanismo de acción del S4, receptor de andrógenos, estructura molecular, estudios preclínicos, tejido muscular, metabolismo óseo, alteraciones visuales, información de seguridad, evidencia clínica limitada.

Italy

Biochem Andarine 10 mg Italia, Andarine S4, Andarine 100 capsule, modulatore selettivo del recettore degli androgeni, SARM Andarine, proprietà dell'andarine, meccanismo d'azione S4, recettore degli androgeni, struttura molecolare, studi preclinici, tessuto muscolare, metabolismo osseo, disturbi visivi, informazioni di sicurezza, dati clinici limitati.

Portugal

Biochem Andarine 10 mg Portugal, Andarine S4, Andarine 100 cápsulas, modulador seletivo dos recetores de androgénios, SARM Andarine, propriedades da andarina, mecanismo de ação do S4, recetor de androgénios, estrutura molecular, estudos pré-clínicos, tecido muscular, metabolismo ósseo, alterações visuais, informações de segurança, evidência clínica limitada.

Netherlands

Biochem Andarine 10 mg Nederland, Andarine S4, Andarine 100 capsules, selectieve androgeenreceptormodulator, SARM Andarine, eigenschappen van andarine, werkingsmechanisme S4, androgeenreceptor, moleculaire structuur, preklinisch onderzoek, spierweefsel, botmetabolisme, visuele stoornissen, veiligheidsinformatie, beperkte klinische gegevens.

Belgium

Biochem Andarine 10 mg België, Andarine 10 mg Belgique, Andarine S4, Andarine 100 capsules, selectieve androgeenreceptormodulator, modulateur sélectif des récepteurs aux androgènes, SARM Andarine, eigenschappen van andarine, propriétés de l'andarine, androgeenreceptor, récepteur aux androgènes, preklinisch onderzoek, études précliniques, visuele stoornissen, troubles visuels, veiligheidsinformatie.

Switzerland

Biochem Andarine 10 mg Schweiz, Andarine 10 mg Suisse, Andarine S4, Andarine 100 Kapseln, Andarine 100 gélules, selektiver Androgenrezeptormodulator, modulateur sélectif des récepteurs aux androgènes, SARM Andarine, Androgenrezeptor, récepteur aux androgènes, präklinische Studien, études précliniques, Sehstörungen, troubles visuels, Sicherheitsinformationen.

Austria

Biochem Andarine 10 mg Österreich, Andarine S4, Andarine 100 Kapseln, selektiver Androgenrezeptormodulator, SARM Andarine, Andarine Eigenschaften, S4 Wirkungsmechanismus, Androgenrezeptor, Molekülstruktur, präklinische Forschung, Muskelgewebe, Knochenstoffwechsel, Sehstörungen, Sicherheitsinformationen, begrenzte klinische Daten.

Sweden

Biochem Andarine 10 mg Sverige, Andarine S4, Andarine 100 kapslar, selektiv androgenreceptormodulator, SARM Andarine, andarine egenskaper, S4 verkningsmekanism, androgenreceptor, molekylstruktur, prekliniska studier, muskelvävnad, benmetabolism, synstörningar, säkerhetsinformation, begränsade kliniska data.

Norway

Biochem Andarine 10 mg Norge, Andarine S4, Andarine 100 kapsler, selektiv androgenreseptormodulator, SARM Andarine, andarine egenskaper, S4 virkningsmekanisme, androgenreseptor, molekylstruktur, prekliniske studier, muskelvev, benmetabolisme, synsforstyrrelser, sikkerhetsinformasjon, begrensede kliniske data.

Denmark

Biochem Andarine 10 mg Danmark, Andarine S4, Andarine 100 kapsler, selektiv androgenreceptormodulator, SARM Andarine, andarine egenskaber, S4 virkningsmekanisme, androgenreceptor, molekylstruktur, prækliniske studier, muskelvæv, knoglemetabolisme, synsforstyrrelser, sikkerhedsinformation, begrænsede kliniske data.

Finland

Biochem Andarine 10 mg Suomi, Andarine S4, Andarine 100 kapselia, selektiivinen androgeenireseptorin muuntelija, SARM Andarine, andariinin ominaisuudet, S4 vaikutusmekanismi, androgeenireseptori, molekyylirakenne, prekliiniset tutkimukset, lihaskudos, luuaineenvaihdunta, näköhäiriöt, turvallisuustiedot, rajallinen kliininen näyttö.

Poland

Biochem Andarine 10 mg Polska, Andarine S4, Andarine 100 kapsułek, selektywny modulator receptora androgenowego, SARM Andarine, właściwości andaryny, mechanizm działania S4, receptor androgenowy, struktura molekularna, badania przedkliniczne, tkanka mięśniowa, metabolizm kości, zaburzenia widzenia, informacje o bezpieczeństwie, ograniczone dane kliniczne.

Czech Republic

Biochem Andarine 10 mg Česko, Andarine S4, Andarine 100 kapslí, selektivní modulátor androgenového receptoru, SARM Andarine, vlastnosti andarinu, mechanismus účinku S4, androgenový receptor, molekulární struktura, preklinické studie, svalová tkáň, kostní metabolismus, poruchy vidění, bezpečnostní informace, omezené klinické údaje.

Romania

Biochem Andarine 10 mg România, Andarine S4, Andarine 100 capsule, modulator selectiv al receptorilor androgenici, SARM Andarine, proprietăți andarina, mecanism de acțiune S4, receptor androgenic, structură moleculară, studii preclinice, țesut muscular, metabolism osos, tulburări de vedere, informații de siguranță, date clinice limitate.

Greece

Biochem Andarine 10 mg Ελλάδα, ανδαρίνη S4, Andarine 100 κάψουλες, εκλεκτικός τροποποιητής υποδοχέων ανδρογόνων, SARM Andarine, ιδιότητες ανδαρίνης, μηχανισμός δράσης S4, υποδοχέας ανδρογόνων, μοριακή δομή, προκλινικές μελέτες, μυϊκός ιστός, μεταβολισμός οστών, διαταραχές όρασης, πληροφορίες ασφάλειας, περιορισμένα κλινικά δεδομένα.

Ireland

Biochem Andarine 10mg Ireland, Andarine S4 Ireland, Andarine 100 capsules, selective androgen receptor modulator, S4 SARM, Andarine pharmacology, Andarine molecular structure, S4 androgen receptor activity, Andarine preclinical studies, S4 muscle tissue research, Andarine bone metabolism, Andarine visual disturbances, S4 safety information, limited human clinical evidence.

Colombia

Biochem Andarine 10 mg Colombia, Andarine S4 Colombia, Andarine 100 cápsulas, andarina 10 mg, modulador selectivo del receptor de andrógenos, SARM andarina, propiedades de la andarina, cómo funciona el S4, farmacología de la andarina, receptor de andrógenos, estructura molecular, estudios preclínicos, tejido muscular, metabolismo óseo, alteraciones visuales, información de seguridad, evidencia clínica limitada.

Argentina

Biochem Andarine 10 mg Argentina, Andarine S4 Argentina, Andarine 100 cápsulas, andarina 10 mg, modulador selectivo del receptor de andrógenos, SARM andarina, propiedades de la andarina, qué es el S4, mecanismo de acción de la andarina, receptor androgénico, estructura molecular, estudios preclínicos, tejido muscular, metabolismo óseo, alteraciones de la visión, información de seguridad.

México

Biochem Andarine 10 mg México, Andarine S4 México, Andarine 100 cápsulas, andarina 10 mg, modulador selectivo del receptor de andrógenos, SARM Andarine, propiedades de la andarina, para qué se estudió el S4, cómo funciona la andarina, farmacología del S4, receptor de andrógenos, estructura molecular, estudios preclínicos, metabolismo óseo, alteraciones visuales, evidencia clínica limitada.

Perú

Biochem Andarine 10 mg Perú, Andarine S4 Perú, Andarine 100 cápsulas, andarina 10 mg, modulador selectivo del receptor de andrógenos, SARM andarina, propiedades de la andarina, mecanismo de acción del S4, farmacología de la andarina, receptor de andrógenos, estructura molecular, estudios preclínicos, tejido muscular, metabolismo óseo, alteraciones visuales, información de seguridad.

Venezuela

Biochem Andarine 10 mg Venezuela, Andarine S4 Venezuela, Andarine 100 cápsulas, andarina 10 mg, modulador selectivo del receptor de andrógenos, SARM Andarine, propiedades de la andarina, qué es el S4, cómo actúa la andarina, farmacología del S4, receptor de andrógenos, estructura molecular, estudios preclínicos, metabolismo óseo, alteraciones visuales, evidencia clínica limitada.

Ecuador

Biochem Andarine 10 mg Ecuador, Andarine S4 Ecuador, Andarine 100 cápsulas, andarina 10 mg, modulador selectivo del receptor de andrógenos, SARM Andarine, propiedades de la andarina, cómo funciona el S4, farmacología de la andarina, mecanismo de acción, receptor de andrógenos, estructura molecular, estudios preclínicos, tejido muscular, metabolismo óseo, alteraciones visuales, información de seguridad.

Biochem Andarine (S-4) 10mg | 100 Capsules | Selective Androgen Receptor Modulator

Learn about Biochem Andarine S-4 10mg, 100 capsules. This product contains andarine, a nonsteroidal selective androgen receptor modulator studied in preclinical muscle and bone research, with limited human safety data.

Biochem Andarine (S-4) 10mg | 100 Cápsulas | Modulador Selectivo del Receptor de Andrógenos

Conoce Biochem Andarine S-4 10mg, 100 cápsulas. Este producto contiene andarina, un modulador selectivo no esteroideo del receptor de andrógenos estudiado en investigaciones preclínicas de músculo y hueso, con datos limitados de seguridad en humanos.

biochem-andarine-s4-10mg-100-capsules

biochem-andarine-s4-10mg-100-capsulas

Biochem Andarine S-4 10mg, 100 oral capsules containing andarine, a nonsteroidal selective androgen receptor modulator associated with preclinical androgen receptor, muscle tissue, and bone metabolism research.

Biochem Andarine S-4 10mg, 100 cápsulas orales que contienen andarina, un modulador selectivo no esteroideo del receptor de andrógenos relacionado con estudios preclínicos de tejido muscular y metabolismo óseo.